FROM THE NEW YORK TIMES: A BETTER ALTERNATIVE TO STATINS?

default image

  This story was in the headlines today. Merck finally got the results they were looking for on their drug Vytorin. Note that the drug did not lower plaque build-up and that all the subjects in the test were eating a low-fat / low-cholesterol diet. Vytorin (a combination of ezetimibe and a statin) showed a slight improvement over a statin alone,…

Continue reading